William Blair Brokers Lower Earnings Estimates for Avantor

Avantor, Inc. (NYSE:AVTR) – Equities research analysts at William Blair cut their Q1 2025 EPS estimates for Avantor in a note issued to investors on Monday, October 28th. William Blair analyst M. Larew now anticipates that the company will post earnings per share of $0.25 for the quarter, down from their previous estimate of $0.29. The consensus estimate for Avantor’s current full-year earnings is $1.01 per share. William Blair also issued estimates for Avantor’s Q2 2025 earnings at $0.30 EPS and FY2025 earnings at $1.18 EPS.

AVTR has been the subject of several other reports. Wells Fargo & Company reduced their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday. Stifel Nicolaus lifted their target price on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Robert W. Baird dropped their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday. Citigroup lowered shares of Avantor from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $30.00 to $23.00 in a research note on Wednesday, July 10th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $27.57.

Avantor Price Performance

Shares of NYSE:AVTR opened at $22.45 on Wednesday. The firm has a market cap of $15.25 billion, a price-to-earnings ratio of 57.56, a P/E/G ratio of 2.93 and a beta of 1.33. Avantor has a 1 year low of $17.06 and a 1 year high of $28.00. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The business has a fifty day simple moving average of $25.32 and a 200 day simple moving average of $24.21.

Insider Activity at Avantor

In related news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.50% of the company’s stock.

Institutional Trading of Avantor

Institutional investors have recently bought and sold shares of the stock. Boston Partners raised its stake in shares of Avantor by 2.2% in the first quarter. Boston Partners now owns 28,561,802 shares of the company’s stock valued at $729,298,000 after acquiring an additional 624,369 shares during the last quarter. Canada Pension Plan Investment Board boosted its stake in Avantor by 6.8% in the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock worth $486,059,000 after purchasing an additional 1,463,695 shares in the last quarter. 1832 Asset Management L.P. grew its holdings in shares of Avantor by 1,634.9% during the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock worth $180,839,000 after purchasing an additional 8,038,451 shares during the last quarter. Bessemer Group Inc. increased its stake in shares of Avantor by 4.4% in the first quarter. Bessemer Group Inc. now owns 7,099,848 shares of the company’s stock valued at $181,544,000 after buying an additional 297,534 shares in the last quarter. Finally, Robeco Schweiz AG raised its holdings in shares of Avantor by 5.0% in the second quarter. Robeco Schweiz AG now owns 6,006,985 shares of the company’s stock valued at $127,348,000 after buying an additional 287,717 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.